Moon Shinje, Kim Yoon Jung, Chung Hye Soo, Yu Jae Myung, Park Il In, Park Sung Gon, Pak Sahyun, Kwon Ohseong, Lee Young Goo, Cho Sung Tae
Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Int Neurourol J. 2022 Jun;26(2):144-152. doi: 10.5213/inj.2142370.185. Epub 2022 Jun 30.
We investigated the relationship between nocturia and mortality risk in the United States.
Data were obtained from the National Health and Nutrition Examination Survey 2005-2010. Mortality data were obtained by linking the primary database to death certificate data found in the National Death Index with mortality follow-up up to December 31, 2015. Nocturia was defined based on symptoms reported in the symptom questionnaire. We categorized patients into 2 groups: mild nocturia (2-3 voids/night) and moderate-to severe nocturia (≥4 voids/night). Multiple Cox regression analyses were performed with adjustment for confounding variables at the baseline survey.
This study included 9,892 adults (4,758 men, 5,134 women). Nocturia occurred in 3,314 individuals (33.5%). Nocturia was significantly associated with all-cause mortality (hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.10-1.39) and cardiovascular disease (CVD) mortality (HR, 1.55; 95% CI, 1.19-2.01). Moreover, the mortality risk increased with increasing nocturia severity. Further analysis with propensity score matching showed that nocturia was still significantly associated with all-cause mortality and CVD mortality. In subgroup analysis according to sex, nocturia was significantly associated with allcause mortality and CVD mortality in men. In women, moderate-to-severe nocturia was significantly associated with allcause mortality and CVD mortality. In subgroup analysis according to cardio-metabolic diseases, nocturia was associated with CVD mortality in patients with diabetes mellitus, hypertension, dyslipidemia, or CVD at baseline. In subgroup analysis of patients without diabetes mellitus, hypertension or CVD, nocturia was significantly associated with all-cause mortality.
Nocturia was significantly associated with mortality in men and women after adjusting for major confounding factors.
我们研究了美国夜尿症与死亡风险之间的关系。
数据来自2005 - 2010年国家健康与营养检查调查。通过将主要数据库与国家死亡指数中的死亡证明数据相链接获取死亡率数据,死亡率随访至2015年12月31日。夜尿症根据症状问卷中报告的症状来定义。我们将患者分为两组:轻度夜尿症(每晚排尿2 - 3次)和中度至重度夜尿症(每晚排尿≥4次)。在基线调查时对混杂变量进行调整后进行了多项Cox回归分析。
本研究纳入了9892名成年人(4758名男性,5134名女性)。3314人(33.5%)出现夜尿症。夜尿症与全因死亡率(风险比[HR],1.23;95%置信区间[CI],1.10 - 1.39)和心血管疾病(CVD)死亡率(HR,1.55;95% CI,1.19 - 2.01)显著相关。此外,死亡风险随着夜尿症严重程度的增加而升高。倾向得分匹配的进一步分析表明,夜尿症仍与全因死亡率和CVD死亡率显著相关。在按性别进行的亚组分析中,夜尿症与男性的全因死亡率和CVD死亡率显著相关。在女性中,中度至重度夜尿症与全因死亡率和CVD死亡率显著相关。在按心血管代谢疾病进行的亚组分析中,夜尿症与基线时患有糖尿病、高血压、血脂异常或CVD的患者的CVD死亡率相关。在无糖尿病、高血压或CVD的患者亚组分析中,夜尿症与全因死亡率显著相关。
在调整主要混杂因素后,夜尿症与男性和女性的死亡率显著相关。